Author： Halevy D. Radhakrishnan J.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.5, 2000-05, pp. : 1053-1063
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cyclosporin A: A Therapeutic Strategy in Allergic Diseases
Letters in Drug Design & Discovery, Vol. 1, Iss. 4, 2004-10 ,pp. :
Access to resources
Recommend
Targeting Leukocytes in Immune Glomerular Diseases
Current Medicinal Chemistry, Vol. 15, Iss. 5, 2008-02 ,pp. :
Topical 0.05% cyclosporin in the treatment of dry eye
By Perry Henry D Donnenfeld Eric D
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. :
Cyclosporin was effective in the treatment of a patient with primary erythromelalgia
Inpharma, Vol. 1, Iss. 1402, 2003-01 ,pp. :